New study tracks immune system clues in leukemia transplant patients

NCT ID NCT03921047

First seen Dec 18, 2025 · Last updated May 16, 2026 · Updated 23 times

Summary

This study looks at how the immune system's T-cells change in people with acute myeloid leukemia (AML) after a stem cell transplant. Researchers will analyze blood samples from 250 participants to see if T-cell patterns can predict complications like graft-versus-host disease or relapse. The goal is to better understand the immune system's role in recovery, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • USC / Norris Comprehensive Cancer Center

    RECRUITING

    Los Angeles, California, 90033, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.